Author:
Meyerhardt Jeffrey A.,Zhu Andrew X.,Stuart Keith,Ryan David P.,Blaszkowsky Lawrence,Lehman Nicole,Earle Craig C.,Kulke Matthew H.,Bhargava Pankaj,Fuchs Charles S.
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference29 articles.
1. Jemal A, Siegel R, Ward E et al (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106–130
2. Burris HA 3rd, Moore MJ, Andersen J et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403–2413
3. Eng C, Ramanathan RK, Wong MK et al (2004) A phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma. Am J Clin Oncol 27:565–569
4. Gebbia V, Giuliani F, Maiello E et al (2001) Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. J Clin Oncol 19:4089–4091
5. Kubicka S, Rudolph KL, Tietze MK et al (2001) Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. Hepatogastroenterology 48:783–789
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献